Emergent BioSolutions Inc. — Director's Dealing 2024

Mar 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-03-13

Reporting Person: Fox Jennifer Lynne (EVP, Ext Aff, GC, Corp Sec)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-13	Employee Stock Options (Right to Buy)	$2.33	A	125000	Acquired	2031-03-12	Common Stock (125000)	Direct

Footnotes

F1: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.